The new capabilities enable health systems to deliver a broader spectrum of virtual care services and to streamline diagnostic testing orders.
A unique virtual back pain treatment program, Teladoc Back Care addresses the high cost condition with improved outcomes for patients, employers.
Teladoc Health announced that Mark Hirschhorn has resigned as Executive Vice President, Chief Operating Officer & Chief Financial Officer for Teladoc Health, as of January 1, 2019.
Teladoc Health (NYSE: TDOC), the global leader in virtual care, is issuing the following statement in response to a report published today referencing an incident from 2016.
Teladoc Health announces the launch of Best Doctors Specialty Pharmacy Services to tackle rising prescription drug costs, using advanced analytics and an expert medical opinion.
Together with the University of Southern California, Teladoc Health will be leading the first-ever, large-scale study to assess antibiotic prescribing practices in telehealth.
Teladoc Health and Thomas Jefferson University announce partnership to create the industry’s first academic fellowship program in the field of telehealth.
Teladoc Health, Inc., announces the financial results for the third quarter ending September 30, 2018.
Teladoc Health announces the appointment of nationally-recognized health policy and delivery system expert, Mark Douglas Smith, MD, MBA, to its board of directors.
Teladoc Health annouces the availability of Oncology Insight to Sun Life Financial clients, providing patients facing cancer access to the world’s leading oncologists.